TMCI PEER ANALYSIS

Treace Medical Concepts Inc — metric-by-metric comparison with peers and the industry median

TMCITreace Medical Concepts Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

TMCIIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	TMCI	SN	ONCSM	MEDTR	4DX	ANGEN	Ind. Median
P/E	—	20.73●	122.41	596.83	—	—	26.82
P/B	3.82	2.50	13.36	1.08	-76.08●	1.32	2.50
EV/EBITDA	—	9.94●	25.46	10.93	—	34.77	15.54
P/S	1.42	2.10	7.66	1.18●	249.46	2.95	2.69

Financial Health
Metric	TMCI	SN	ONCSM	MEDTR	4DX	ANGEN	Ind. Median
Current Ratio	3.58	2.57	2.25	3.58	6.57●	2.31	3.28
Debt/Equity	17.6%	62.9%	35.0%	1.0%	-22.6%●	28.1%	44.7%
NetDebt/EBITDA	0.83	1.72	0.42	-1.64●	0.71	4.71	0.82

Profitability
Metric	TMCI	SN	ONCSM	MEDTR	4DX	ANGEN	Ind. Median
Net Margin	-29.4%	10.1%●	6.3%	0.2%	-3,684.6%	-45.0%	-5.7%
ROE	-66.9%	12.1%	12.9%●	0.2%	—	-21.0%	-8.6%
ROA	-31.3%	6.1%	8.0%●	0.2%	-264.3%	-15.7%	-6.4%
EBITDA Margin	-22.3%	25.6%	30.6%●	9.4%	-818.8%	9.8%	5.2%

Growth + Dividend
Metric	TMCI	SN	ONCSM	MEDTR	4DX	ANGEN	Ind. Median
Rev. Growth	-1.7%	—	39.1%●	6.5%	-26.0%	11.7%	7.4%
NI Growth	—	—	—	-62.9%	—	—	16.7%
Div. Yield	—	3.5%●	0.0%	1.1%	—	0.0%	1.1%
Payout	—	52.8%	0.0%	656.3%	—	0.0%	39.0%

Valuation
Metric	TMCI	SGHT	RXST	MASS	INFU	QTRX	Ind. Median
P/E	—	—	—	—	26.33	—	26.82
P/B	3.82	5.48	0.87	2.31	3.55	0.71●	2.50
EV/EBITDA	—	—	—	—	8.86	—	15.54
P/S	1.42	3.72	1.81	5.36	1.46	1.39●	2.69

Financial Health
Metric	TMCI	SGHT	RXST	MASS	INFU	QTRX	Ind. Median
Current Ratio	3.58	5.86	10.20●	3.58	2.14	3.72	3.28
Debt/Equity	17.6%	77.5%	4.1%	3.3%●	38.8%	12.5%	44.7%
NetDebt/EBITDA	0.83	1.36	4.79	4.04	0.80	0.76●	0.82

Profitability
Metric	TMCI	SGHT	RXST	MASS	INFU	QTRX	Ind. Median
Net Margin	-29.4%	-46.8%	-36.6%	-62.1%	5.6%●	-71.9%	-5.7%
ROE	-66.9%	-56.6%	-17.1%	-24.5%	13.9%●	-34.8%	-8.6%
ROA	-31.3%	-31.1%	-15.1%	-18.8%	7.8%●	-27.3%	-6.4%
EBITDA Margin	-22.3%	-39.8%	-33.9%	-46.0%	18.2%●	-58.4%	5.2%

Growth + Dividend
Metric	TMCI	SGHT	RXST	MASS	INFU	QTRX	Ind. Median
Rev. Growth	-1.7%	1.8%	-19.5%	2.2%	3.5%	8.2%●	7.4%
NI Growth	—	—	—	—	148.0%	—	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on TMCI

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.